Laird Norton Wetherby Trust Company’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Sell
27,342
-5,961
-18% -$266K 0.02% 469
2026
Q1
$1.6M Sell
33,303
-6,549
-16% -$305K 0.04% 361
2025
Q4
$1.93M Buy
+39,852
New +$1.98M 0.04% 326

Other funds holding SNY

Laird Norton Wetherby Trust Company's SNY Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its Sanofi (SNY) stake by 18% in Q2 2026, selling an estimated $266K and leaving 27,342 shares worth $1.17M. The position accounts for 0.02% of the portfolio, ranked #469.

Laird Norton Wetherby Trust Company first reported a position in SNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.93M in Q4 2025. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 27,342 shares of Sanofi worth $1.17M as of Q2 2026.
  • Laird Norton Wetherby Trust Company sold 5,961 Sanofi shares in Q2 2026, an estimated $266K.
  • Sanofi made up 0.02% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #469 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Sanofi in Q4 2025 and has held it in 3 quarters since.
  • Laird Norton Wetherby Trust Company's Sanofi position peaked at $1.93M in Q4 2025.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.